Inhibition of Matrix Degrading Enzymes and Invasion in Human Glioblastoma (U87MG) Cells by Isoflavones

Overview

Journal J Neurooncol

Publisher Springer

Date 2006 Apr 7

PMID 16598420

Citations 26

Authors

Shilpa Puli

James C K Lai

Alok Bhushan

Affiliations

Soon will be listed here.

Abstract

Glioblastoma multiforme is a primary brain tumor associated with extensive invasion into surrounding brain tissue. Matrix metalloproteinases (MMPs) and urokinase plasminogen activation (uPA) system are shown to be involved in tumor invasion as they help in degradation of extracellular matrix (ECM) proteins and thus assist in the movement of cells. MMP-2 and 9 were shown to be upregulated in gliomas, suggesting their involvement in invasion. Genistein and biochanin A are isoflavones commonly known as phytoestrogens and have some anticancer properties. We hypothesize that these two isoflavones can induce a lowering of tumor invasion by decreasing the activity of matrix degrading enzymes. In this study we investigated the effects of genistein and biochanin A on invasive activity of U87MG cells using the Calbiochem in vitro invasion assay system. Our results suggest that genistein and biochanin A induced a decrease in invasive activity of U87MG cells in a dose-related manner. Genistein also induced a decrease in EGF-stimulated invasion thereby implicating an involvement of EGF-mediated signaling in invasion. Our results also show that treatment of U87MG cells with the two isoflavones induced decreases in the enzymatic activity of MMP-9 and the protein levels of MT1-MMP and uPAR.

Citing Articles

Biochanin A Inhibits the Growth and Biofilm of Species.

Janeczko M, Kochanowicz E Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256922 PMC: 10818846. DOI: 10.3390/ph17010089.

Mechanisms Behind the Pharmacological Application of Biochanin-A: A review.

Anuranjana P, Beegum F, K P D, George K, Viswanatha G, Nayak P F1000Res. 2023; 12:107.

PMID: 38106650 PMC: 10725524. DOI: 10.12688/f1000research.126059.3.

Anticancer Mechanism of Flavonoids on High-Grade Adult-Type Diffuse Gliomas.

Wong S, Kamarudin M, Naidu R Nutrients. 2023; 15(4).

PMID: 36839156 PMC: 9964830. DOI: 10.3390/nu15040797.

Recent Advances in Pharmaceutical Cocrystals: A Focused Review of Flavonoid Cocrystals.

Xu J, Shi Q, Wang Y, Wang Y, Xin J, Cheng J Molecules. 2023; 28(2).

PMID: 36677670 PMC: 9861466. DOI: 10.3390/molecules28020613.

Tetrahydrocannabinol-Rich Extracts From L. Improve Glucose Consumption and Modulate Metabolic Complications Linked to Neurodegenerative Diseases in Isolated Rat Brains.

Erukainure O, Matsabisa M, Salau V, Islam M Front Pharmacol. 2021; 11:592981.

PMID: 33390972 PMC: 7774498. DOI: 10.3389/fphar.2020.592981.

References

Ellerbroek S, Halbleib J, Benavidez M, Warmka J, Wattenberg E, Stack M . Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Res. 2001; 61(5):1855-61. View

Mohanam S, Chintala S, Go Y, Bhattacharya A, Venkaiah B, Boyd D . In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene. 1997; 14(11):1351-9. DOI: 10.1038/sj.onc.1200963. View

Barnes S, PETERSON T . Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med. 1995; 208(1):103-8. DOI: 10.3181/00379727-208-43840. View

Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N . Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987; 262(12):5592-5. View

Deryugina E, Bourdon M, Luo G, Reisfeld R, Strongin A . Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci. 1997; 110 ( Pt 19):2473-82. DOI: 10.1242/jcs.110.19.2473. View

Lund-Johansen M, Bjerkvig R, Humphrey P, Bigner S, Bigner D, Laerum O . Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res. 1990; 50(18):6039-44. View

Cox G, Jones J, OByrne K . Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Clin Cancer Res. 2000; 6(6):2349-55. View

Lee Y, Seo J, Chung H, Jang J . Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyrene. J Korean Med Sci. 1991; 6(4):325-8. PMC: 3049714. DOI: 10.3346/jkms.1991.6.4.325. View

Lakka S, Gondi C, Yanamandra N, Dinh D, Olivero W, Gujrati M . Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Cancer Res. 2003; 63(10):2454-61. View

10.

Vihinen P, Kahari V . Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer. 2002; 99(2):157-66. DOI: 10.1002/ijc.10329. View

11.

Choe G, Park J, Kremen T, Liau L, Vinters H, Cloughesy T . Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res. 2002; 8(9):2894-901. View

12.

Penar P, Khoshyomn S, Bhushan A, Tritton T . Inhibition of glioma invasion of fetal brain aggregates. In Vivo. 1998; 12(1):75-84. View

13.

Ouyang Y, Peng Z, Yao X, Liu S, He Y . [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004; 35(3):330-3. View

14.

Hempstock J, Kavanagh J, George N . Growth inhibition of prostate cell lines in vitro by phyto-oestrogens. Br J Urol. 1998; 82(4):560-3. DOI: 10.1046/j.1464-410x.1998.00769.x. View

15.

Hess A, Seftor E, Seftor R, Hendrix M . Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res. 2003; 63(16):4757-62. View

16.

Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus H . Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis. 1994; 12(4):296-304. DOI: 10.1007/BF01753836. View

17.

Bello L, Giussani C, Carrabba G, Pluderi M, Costa F, Bikfalvi A . Angiogenesis and invasion in gliomas. Cancer Treat Res. 2004; 117:263-84. DOI: 10.1007/978-1-4419-8871-3_16. View

18.

Visse R, Nagase H . Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003; 92(8):827-39. DOI: 10.1161/01.RES.0000070112.80711.3D. View

19.

Tsatas D, Kaye A . The role of the plasminogen activation cascade in glioma cell invasion: a review. J Clin Neurosci. 2003; 10(2):139-45. DOI: 10.1016/s0967-5868(02)00328-4. View

20.

Mohanam S, Gladson C, Rao C, Rao J . Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors. Front Biosci. 1999; 4:D178-87. DOI: 10.2741/mohanam. View